The Role of Aberrant Epigenetic Silencing of NR4A3 and LOXL4 in Gastric Cancer

The Role of Aberrant Epigenetic Silencing of NR4A3 and LOXL4 in Gastric Cancer

碩士 === 國立中正大學 === 生物醫學研究所 === 101 === Gastric cancer is the second leading cause of cancer worldwide. Epigenetic silencing of tumor-suppressors has emerged as an important underlying mechanism in the gastric carcinogenesis. Previous studies showed that infection of H. pylori activates JAK/STAT3 sign...

Full description

Bibliographic Details
Main Authors:	Li-Han Zeng, 曾莉涵
Other Authors:	Michael Wing-Yan Chan
Format:	Others
Language:	en_US
Published:	2013
Online Access:	http://ndltd.ncl.edu.tw/handle/14964412777784051791

Similar Items

Epigenetic Silencing of NR4A3 by Aberrant JAK/STAT Signaling is Associated with Poor Prognosis in Gastric Cancer
by: Alex Liang-yu Chang, et al.
Published: (2011)

The role of aberrant TGF-β /Smad4 signaling in epigenetic silencing of RunX1T1 in ovarian cancer and cancer initiating cells
by: Hui-Wen Yang, et al.
Published: (2009)

LAMA2 and LOXL4 are candidate FSGS genes
by: Poornima Vijayan, et al.
Published: (2021-09-01)

Epigenetic silencing of miR‐1271 enhances MEK1 and TEAD4 expression in gastric cancer
by: Byungho Lim, et al.
Published: (2018-07-01)

Aberrant JAK/STAT Signaling Suppresses TFF1 and TFF2 through Epigenetic Silencing of GATA6 in Gastric Cancer
by: Cheng-Shyong Wu, et al.
Published: (2016-09-01)

LOXL3 Silencing Affected Cell Adhesion and Invasion in U87MG Glioma Cells
by: Talita de S. Laurentino, et al.
Published: (2021-07-01)

Epigenetic Silencing of ID4 in Prostate Cancer: Mechanistic Insight
by: Chinaranagari, Swathi
Published: (2015)

LOXL3 Function Beyond Amino Oxidase and Role in Pathologies, Including Cancer
by: Talita de S. Laurentino, et al.
Published: (2019-07-01)

HOXD-AS1 confers cisplatin resistance in gastric cancer through epigenetically silencing PDCD4 via recruiting EZH2
by: Yafei Ye, et al.
Published: (2019-09-01)

Epigenetic aberrations and cancer
by: Brown Mark A, et al.
Published: (2006-11-01)

Aberrant epigenetic silencing is triggered by a transient reduction in gene expression.
by: Jon A Oyer, et al.
Published: (2009-01-01)

Galanin is an epigenetically silenced tumor suppressor gene in gastric cancer cells.
by: Daseul Yoon, et al.
Published: (2018-01-01)

Potential association of LOXL1 with peritoneal dissemination in gastric cancer possibly via promotion of EMT.
by: Qingjiang Hu, et al.
Published: (2020-01-01)

Clinical Significance of Epigenetic Silencing of ARNTL and DCC in Ovarian Cancer
by: Ting-Chuan Zeng, et al.
Published: (2013)

LOXL2 Inhibitors and Breast Cancer Progression
by: Sandra Ferreira, et al.
Published: (2021-02-01)

Epigenetic Silencing of CXCR4 Promotes Loss of Cell Adhesion in Cervical Cancer
by: Suresh Singh Yadav, et al.
Published: (2014-01-01)

Barn nr 3-4 2018
by: - -
Published: (2019-01-01)

Molecular roles of Lysyl Oxidase-Like 3 (LOXL3) in melanoma proliferation and progression
by: Zhang, Xue
Published: (2017)

Exosome-mediated secretion of LOXL4 promotes hepatocellular carcinoma cell invasion and metastasis
by: Rongkun Li, et al.
Published: (2019-01-01)

The lncRNA GATA6-AS epigenetically regulates endothelial gene expression via interaction with LOXL2
by: Philipp Neumann, et al.
Published: (2018-01-01)

Novel Non-Coding Transcript in NR4A3 Locus, LncNR4A3, Regulates RNA Processing Machinery Proteins and NR4A3 Expression
by: Ada Congrains, et al.
Published: (2020-11-01)

Galimybė Nr.4
by: Viselgė, Vita
Published: (2013)

The LOX and LOXL2 amine oxidases in colon and esophageal cancer
by: Fong, Sheri Fumiko Tsuda
Published: (2008)

LOXL1-AS1 Drives The Progression Of Gastric Cancer Via Regulating miR-142-5p/PIK3CA Axis
by: Li M, et al.
Published: (2019-12-01)

Epigenetic silencing of miR-338-3p contributes to tumorigenicity in gastric cancer by targeting SSX2IP.
by: Pu Li, et al.
Published: (2013-01-01)

Epigenetic Silencing of DKK3 in Medulloblastoma
by: André Oberthuer, et al.
Published: (2013-04-01)

LOXL4 Abrogation Does Not Exaggerate Angiotensin II-Induced Thoracic or Abdominal Aortic Aneurysm in Mice
by: Huimin Li, et al.
Published: (2021-03-01)

2009, Nr. 4, Turinys
by: Žurnalo Archyvas
Published: (2018-10-01)

Linking LOXL2 to Cardiac Interstitial Fibrosis
by: Melisse Erasmus, et al.
Published: (2020-08-01)

”Studii di sociologia” nr. 3-4, 1988
by: C. Caciuc
Published: (1991-08-01)

LOXL1 exerts oncogenesis and stimulates angiogenesis through the LOXL1-FBLN5/αvβ3 integrin/FAK-MAPK axis in ICC
by: Ruiyan Yuan, et al.
Published: (2021-03-01)

Role of DNA methylation and epigenetic silencing of HAND2 in endometrial cancer development.
by: Allison Jones, et al.
Published: (2013-11-01)

Epigenetic Targeting of Aberrant Transcriptional Modulation in Pancreatic Cancer
by: Feda H. Hamdan, et al.
Published: (2018-05-01)

NR4A2 is regulated by gastrin and influences cellular responses of gastric adenocarcinoma cells.
by: Kristine Misund, et al.
Published: (2013-01-01)

Nr4a1 suppresses cocaine-induced behavior via epigenetic regulation of homeostatic target genes
by: Marco D. Carpenter, et al.
Published: (2020-01-01)

Nr4a1 and Nr4a3 Reporter Mice Are Differentially Sensitive to T Cell Receptor Signal Strength and Duration
by: Emma Jennings, et al.
Published: (2020-11-01)

Epigenetic Aberrations in Multiple Myeloma
by: Cinzia Caprio, et al.
Published: (2020-10-01)

Novel role of LOXL2 in TMJ and knee OA cartilage in vitro and in vivo
by: Alshenibr, Weam
Published: (2018)

Writing of H3K4Me3 overcomes epigenetic silencing in a sustained but context-dependent manner
by: David Cano-Rodriguez, et al.
Published: (2016-08-01)

LOXL 2 Promotes The Epithelial–Mesenchymal Transition And Malignant Progression Of Cervical Cancer
by: Tian J, et al.
Published: (2019-10-01)